Evidence map›Paper›PMID 35310621›Full record

ArticleVirus evolution2022

Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area.

Sarah C Brüningk, Juliane Klatt, Madlen Stange, Alfredo Mari, Myrta Brunner, Tim-Christoph Roloff, Helena M B Seth-Smith, Michael Schweitzer, Karoline Leuzinger, Kirstine K Søgaard and 21 more

Registry-linked trialAbstract read
In one paragraph

Article in Virus evolution, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04351503 (A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City), which is not on this map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04351503 completednot on this map

A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City

TypeobservationalSponsorUniversity Hospital, Basel, SwitzerlandRan2020 to 2022Enrolled126,586ConditionsSARS Coronavirus (SARS-CoV-2) InfectionArmsStudy A, Study B, Study C, Study D
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Inferring COVID-19 testing and vaccination behavior from New Jersey testing data.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Von Willebrand factor and the thrombophilia of severe COVID-19:Research and practice in thrombosis and haemostasis · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Juliane KlattMachine Learning & Computational Biology, Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
Madlen StangeSwiss Institute for Bioinformatics (SIB), Lausanne, Switzerland.
Alfredo MariSwiss Institute for Bioinformatics (SIB), Lausanne, Switzerland.ORCID https://orcid.org/0000-0002-3871-088X
Myrta BrunnerApplied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
Tim-Christoph RoloffSwiss Institute for Bioinformatics (SIB), Lausanne, Switzerland.
Helena M B Seth-SmithSwiss Institute for Bioinformatics (SIB), Lausanne, Switzerland.
Michael SchweitzerApplied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
Karoline LeuzingerClinical Virology, University Hospital Basel & University of Basel, Basel, Switzerland.
Kirstine K SøgaardApplied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
Diana Albertos TorresApplied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
Alexander GenschApplied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
Ann-Kathrin SchlotterbeckApplied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
Christian H NickelEmergency Department, University Hospital Basel, Basel, Switzerland.
Nicole RitzPaediatric Infectious Diseases and Vaccinology, University of Basel Children's Hospital Basel and University of Basel, Basel, Switzerland.
Ulrich HeiningerPaediatric Infectious Diseases and Vaccinology, University of Basel Children's Hospital Basel and University of Basel, Basel, Switzerland.
Julia BielickiPaediatric Infectious Diseases and Vaccinology, University of Basel Children's Hospital Basel and University of Basel, Basel, Switzerland.
Katharina RentschLaboratory Medicine, University Hospital Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0002-6585-9778
Simon FuchsHealth Services for the Basel-City, Basel, Switzerland.
Roland BingisserEmergency Department, University Hospital Basel, Basel, Switzerland.
Martin SiegemundIntensive Care Medicine, University Hospital Basel, Basel, Switzerland.
Hans ParggerIntensive Care Medicine, University Hospital Basel, Basel, Switzerland.
Diana CiardoViollier AG, Allschwil, Switzerland.
Olivier DubuisViollier AG, Allschwil, Switzerland.
Andreas BuserRegional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland.
Sarah Tschudin-SutterInfectious Diseases and Hospital Epidemiology, University Hospital Basel & University of Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0003-4875-5368
Manuel BattegayInfectious Diseases and Hospital Epidemiology, University Hospital Basel & University of Basel, Basel, Switzerland.
Rita Schneider-SliwaHuman Geography, Department of Environmental Sciences, University of Basel, Basel, Switzerland.
Karsten M BorgwardtMachine Learning & Computational Biology, Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
Hans H HirschClinical Virology, University Hospital Basel & University of Basel, Basel, Switzerland.
Adrian EgliApplied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transmission chains within small urban areas (accommodating ∼30 per cent of the European population) greatly contribute to case burden and economic impact during the ongoing coronavirus pandemic and should be a focus for preventive measures to achieve containment. Here, at very high spatio-temporal resolution, we analysed determinants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in a European urban area, Basel-City (Switzerland). We combined detailed epidemiological, intra-city mobility and socio-economic data sets with whole-genome sequencing during the first SARS-CoV-2 wave. For this, we succeeded in sequencing 44 per cent of all reported cases from Basel-City and performed phylogenetic clustering and compartmental modelling based on the dominating viral variant (B.1-C15324T; 60 per cent of cases) to identify drivers and patterns of transmission. Based on these results we simulated vaccination scenarios and corresponding healthcare system burden (intensive care unit (ICU) occupancy). Transmissions were driven by socio-economically weaker and highly mobile population groups with mostly cryptic transmissions which lacked genetic and identifiable epidemiological links. Amongst more senior population transmission was clustered. Simulated vaccination scenarios assuming 60-90 per cent transmission reduction and 70-90 per cent reduction of severe cases showed that prioritising mobile, socio-economically weaker populations for vaccination would effectively reduce case numbers. However, long-term ICU occupation would also be effectively reduced if senior population groups were prioritised, provided there were no changes in testing and prevention strategies. Reducing SARS-CoV-2 transmission through vaccination strongly depends on the efficacy of the deployed vaccine. A combined strategy of protecting risk groups by extensive testing coupled with vaccination of the drivers of transmission (i.e. highly mobile groups) would be most effective at reducing the spread of SARS-CoV-2 within an urban area.

Identifiers

PMID35310621
PMCPMC8927799

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.